ChiCGB vs BEAM in High-risk or R/R Lymphomas

Clinical trial NCT05466318 · UNKNOWN

Trial details

NCT number: NCT05466318
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse Lymphoma, T-Cell

Start date: 2022-07-01
Primary completion: 2025-12-30
Enrollment: 306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.